Wessler, I; Hölper, B; Kortsik, C et al.
Dysfunctional inhibitory muscarinic receptors mediate enhanced histamine release in isolated human bronchiLife Sci. Bd. 80. H. 24-25. 2007 S. 2294-7
Kuna, P; Peters, MJ; Manjra, AI et al.
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.Int J Clin Pract. Bd. 61. H. 5. 2007 S. 725-36
Morschhauser, F; Illidge, T; Huglo, D et al.
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.Blood. Bd. 110. H. 1. 2007 S. 54-8
Ullmann, AJ; Krammes, E; Sommer, S et al.
Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.J Antimicrob Chemother. Bd. 60. H. 5. 2007 S. 1080-4
Kuball, J; Dossett, ML; Wolfl, M et al.
Facilitating matched pairing and expression of TCR chains introduced into human T cells.Blood. Bd. 109. H. 6. 2007 S. 2331-8
Al-Batran, SE; Hartmann, JT; Heidel, F et al.
Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.Gastric Cancer. Bd. 10. H. 3. 2007 S. 145-52
Bertram, L; Weber, M; Kümmel, WF
Hausaufbahrungen im 20. Jahrhundert - ihre Entwicklung am Beispiel von Mainz-Bretzenheim und Rüdesheim-EibingenVolkskunde Rheinland-Pfalz. Bd. 21. 2007 S. 103-9
Weide, R; Hess, G; Koppler, H et al.
High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).Leuk Lymphoma. Bd. 48. H. 7. 2007 S. 1299-306
Miesbach, W; Scharrer, I; Asherson, RA
High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma.Clin Rheumatol. Bd. 26. H. 1. 2007 S. 95-7
Fruehauf, S; Topaly, J; Buss, EC et al.
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.Cancer. Bd. 109. H. 8. 2007 S. 1543-9